MA38302A1 - Anti-pdgfr-beta antibodies and their uses - Google Patents
Anti-pdgfr-beta antibodies and their usesInfo
- Publication number
- MA38302A1 MA38302A1 MA38302A MA38302A MA38302A1 MA 38302 A1 MA38302 A1 MA 38302A1 MA 38302 A MA38302 A MA 38302A MA 38302 A MA38302 A MA 38302A MA 38302 A1 MA38302 A1 MA 38302A1
- Authority
- MA
- Morocco
- Prior art keywords
- pdgfr
- beta
- antibodies
- diseases
- bind
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La présente invention concerne des anticorps qui se lient au récepteur bêta du facteur de croissance issu des plaquettes (pdgfr-bêta) et des procédés de leur utilisation. Selon certains modes de réalisation de l'invention, les anticorps sont des anticorps complètement humains qui se lient à pdgfr-bêta humain avec une affinité élevée. Les anticorps de l'invention sont utiles pour le traitement de maladies et de troubles associés à la signalisation par pdgfr-bêta et/ou l'expression cellulaire de pdgfr-bêta, tels que des maladies oculaires, des maladies fibrotiques, des maladies vasculaires et le cancer.The present invention relates to antibodies that bind to platelet-derived growth factor beta receptor (pdgfr-beta) and methods of their use. In some embodiments of the invention, the antibodies are fully human antibodies that bind to human pdgfr-beta with high affinity. The antibodies of the invention are useful for the treatment of diseases and disorders associated with pdgfr-beta signaling and / or cellular expression of pdgfr-beta, such as ocular diseases, fibrotic diseases, vascular diseases and the like. the cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361750437P | 2013-01-09 | 2013-01-09 | |
PCT/US2014/010395 WO2014109999A1 (en) | 2013-01-09 | 2014-01-07 | ANTI-PDGFR-beta ANTIBODIES AND USES THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
MA38302A1 true MA38302A1 (en) | 2018-02-28 |
MA38302B1 MA38302B1 (en) | 2018-10-31 |
Family
ID=56117360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA38302A MA38302B1 (en) | 2013-01-09 | 2014-01-07 | Anti-pdgfr-beta antibodies and their uses |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR094379A1 (en) |
MA (1) | MA38302B1 (en) |
-
2014
- 2014-01-07 AR ARP140100052A patent/AR094379A1/en unknown
- 2014-01-07 MA MA38302A patent/MA38302B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR094379A1 (en) | 2015-07-29 |
MA38302B1 (en) | 2018-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA42622B1 (en) | LIAISONS IN TIGIT AND THEIR USES | |
MY202018A (en) | Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies | |
MA45125B1 (en) | Anti-alpha-synuclein antibodies and their uses | |
MA39313A1 (en) | Anti-egfrviii antibodies and their uses in the treatment of various cancers | |
MA44659B1 (en) | ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS | |
MA44312A (en) | ANTIBODIES AND THEIR METHODS OF USE | |
MA40041A (en) | ANTI-GITR ANTIBODIES AND THEIR METHODS OF USE | |
MA47313A (en) | SUBCUTANEOUS FORMULATIONS OF HER2 ANTIBODIES | |
MY169165A (en) | Anti-pdgfr-beta antibodies and uses thereof | |
MA40497A (en) | ANTIBODIES AND CHEMERICAL ANTIGENIC RECEPTORS SPECIFIC TO CD19 | |
MA33534B1 (en) | Human antibodies have a high affinity against human 2 angiobots | |
MX2020011546A (en) | Anti-msr1 antibodies and methods of use thereof. | |
MA37945B1 (en) | Human antibodies to gfr3 and methods of use thereof | |
MA38961A1 (en) | 3-phenyl-1h-pyrazolo [3,4-d] pyrimidin-4-ylamine compounds substituted for the crude tyrosine kinase inhibitors used to treat, for example, autoimmune, respiratory and inflammatory diseases, cancer, mastocytosis and osteoporosis | |
MA32566B1 (en) | ANTIBODIES THAT NEUTRALIZE HUMAN CYTOMEGALOVIRUSES AND USES THEREOF | |
PH12021550690A1 (en) | Anti-hla-g antibodies, compositions comprising anti-hla-g antibodies and methods of using anti-hla-g antibodies | |
MA34277B1 (en) | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | |
MX2013003468A (en) | Anti-cd48 antibodies and uses thereof. | |
MA44334A (en) | ANTIBODY CONJUGATES INCLUDING A TOLL-TYPE RECEPTOR AGONIST | |
PL1830881T3 (en) | Combining therapies targeting multiple toll-like receptors and use thereof | |
MA49727A (en) | ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127 | |
JOP20210323A1 (en) | Multispecific heavy chain antibodies binding to cd22 and cd3 | |
MX2018013072A (en) | Tl1a antibodies and uses thereof. | |
MA39342B2 (en) | Il -21 antibody | |
MX2022016342A (en) | Multi-specific antibodies binding to bcma. |